These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37363780)

  • 21. New perspectives in the diagnosis of pediatric male hypogonadism: the importance of AMH as a Sertoli cell marker.
    Grinspon RP; Rey RA
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):512-9. PubMed ID: 22218431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-Like Factor 3 and the HPG Axis in the Male.
    Ivell R; Heng K; Anand-Ivell R
    Front Endocrinol (Lausanne); 2014; 5():6. PubMed ID: 24478759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of standardised treatments for haematologic malignancies as regards to testicular endocrine function in children and teenagers.
    Grinspon RP; Arozarena M; Prada S; Bargman G; Sanzone M; Morales Bazurto M; Gutiérrez M; Bedecarrás P; Kannemann A; Elena GO; Gottlieb S; Berenstein AJ; Ropelato MG; Bergadá I; Aversa LA; Rey RA
    Hum Reprod; 2019 Dec; 34(12):2480-2494. PubMed ID: 31768530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels.
    Andersson AM; Juul A; Petersen JH; Müller J; Groome NP; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3976-81. PubMed ID: 9398699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty.
    Coutant R; Biette-Demeneix E; Bouvattier C; Bouhours-Nouet N; Gatelais F; Dufresne S; Rouleau S; Lahlou N
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5225-32. PubMed ID: 20826577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism.
    Pitteloud N; Dwyer A
    Ann Endocrinol (Paris); 2014 May; 75(2):98-100. PubMed ID: 24793994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans.
    Young J; Rey R; Schaison G; Chanson P
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):51-4. PubMed ID: 14656476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of insulin-like factor 3, anti-Mullerian hormone, inhibin B, and testosterone during pubertal transition in healthy boys: a longitudinal pilot study.
    Johansen ML; Anand-Ivell R; Mouritsen A; Hagen CP; Mieritz MG; Søeborg T; Johannsen TH; Main KM; Andersson AM; Ivell R; Juul A
    Reproduction; 2014; 147(4):529-35. PubMed ID: 24459206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of Serum Testicular Protein Hormone Measurement in the Assessment of Disorders of Sex Development.
    Freire AV; Grinspon RP; Rey RA
    Sex Dev; 2018; 12(1-3):30-40. PubMed ID: 28850950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypogonadism in Pediatric Health: Adult Medicine Concepts Fail.
    Grinspon RP; Freire AV; Rey RA
    Trends Endocrinol Metab; 2019 Dec; 30(12):879-890. PubMed ID: 31471249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinguishing between hidden testes and anorchia: the role of endocrine evaluation in infancy and childhood.
    Jespersen K; Ljubicic ML; Johannsen TH; Christiansen P; Skakkebaek NE; Juul A
    Eur J Endocrinol; 2020 Jul; 183(1):107-117. PubMed ID: 32422605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone.
    Kohva E; Varimo T; Huopio H; Tenhola S; Voutilainen R; Toppari J; Miettinen PJ; Vaaralahti K; Viinamäki J; Backman JT; Hero M; Raivio T
    Hum Reprod; 2020 Feb; 35(2):257-264. PubMed ID: 31958337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An
    Arato I; Luca G; Mancuso F; Bellucci C; Lilli C; Calvitti M; Hansen BC; Milardi D; Grande G; Calafiore R
    Asian J Androl; 2018; 20(2):160-165. PubMed ID: 29148520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activating mutations in the luteinizing hormone receptor gene: a human model of non-follicle-stimulating hormone-dependent inhibin production and germ cell maturation.
    Soriano-Guillen L; Mitchell V; Carel JC; Barbet P; Roger M; Lahlou N
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3041-7. PubMed ID: 16684832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal insulin-like peptide-3 levels despite low testosterone in adult males with Prader-Willi syndrome: variations in Leydig cell function from infancy through adulthood.
    Hirsch HJ; Eldar-Geva T; Gross-Tsur V; Benarroch F; Roger M; Lahlou N
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E135-43. PubMed ID: 23150680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibin B, follicle stimulating hormone, luteinizing hormone, and estradiol and their relationship to the regulation of follicle development in girls during childhood and puberty.
    Chada M; Průsa R; Bronský J; Pechová M; Kotaska K; Lisá L
    Physiol Res; 2003; 52(3):341-6. PubMed ID: 12790766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
    Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions.
    Allan CM; Haywood M; Swaraj S; Spaliviero J; Koch A; Jimenez M; Poutanen M; Levallet J; Huhtaniemi I; Illingworth P; Handelsman DJ
    Endocrinology; 2001 Jun; 142(6):2213-20. PubMed ID: 11356665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum inhibin B, FSH, LH and testosterone levels before and after human chorionic gonadotropin stimulation in prepubertal boys with cryptorchidism.
    Christiansen P; Andersson AM; Skakkebaek NE; Juul A
    Eur J Endocrinol; 2002 Jul; 147(1):95-101. PubMed ID: 12088925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete Sertoli cell proliferation induced by follicle-stimulating hormone (FSH) independently of luteinizing hormone activity: evidence from genetic models of isolated FSH action.
    Allan CM; Garcia A; Spaliviero J; Zhang FP; Jimenez M; Huhtaniemi I; Handelsman DJ
    Endocrinology; 2004 Apr; 145(4):1587-93. PubMed ID: 14726449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.